The relationship between endothelial function and aortic valve calcification: Multi-Ethnic Study of Atherosclerosis
Related Experiment Video
Updated: Feb 1, 2026

Isolation and Characterization of Primary Rat Valve Interstitial Cells: A New Model to Study Aortic Valve Calcification
Published on: November 20, 2017
Moshrik Abd Alamir1, Michael Goyfman2, Dana Johnson1
1Advocate Lutheran General Hospital, Parkside Ste B-01, 1775 Dempster St, Park Ridge, IL, 60068, USA.
Insights
Endothelial dysfunction, measured by flow-mediated dilation (FMD%) and biomarkers, does not appear to be independently linked to the presence or worsening of aortic valve calcification in a multiethnic group after accounting for cardiac risk factors.
Area of Science:
- Cardiovascular Medicine
- Atherosclerosis Research
- Multi-ethnic Population Studies
Background:
- Aortic valve calcification (AVC) is potentially linked to atherogenic processes driven by endothelial dysfunction (ED).
- Limited data exists on the association between ED markers (flow-mediated dilation [FMD%] and biomarkers) and AVC prevalence/progression in diverse populations.
Purpose of the Study:
- To investigate the relationship between endothelial dysfunction and the prevalence and progression of aortic valve calcification.
- To analyze ED using flow-mediated dilation (FMD%) and various serologic biomarkers in a multiethnic cohort.
Main Methods:
- Utilized data from 3475 Multi-Ethnic Study of Atherosclerosis (MESA) participants with serial CT scans.
- Assessed endothelial dysfunction via FMD% and biomarkers including CRP, vWF, PAI, fibrinogen, IL6, E-selectin, and ICAM-1.
- Employed multivariate modeling to evaluate associations between ED markers and AVC prevalence and progression.
Main Results:
- Individuals with prevalent AVC showed lower FMD% and higher vWF, fibrinogen, IL6, and ICAM-1 levels.
- After adjusting for cardiac risk factors, neither reduced FMD% nor elevated biomarkers were independently associated with AVC prevalence.
- Similarly, AVC progression was not independently linked to FMD% or biomarker levels after risk factor adjustment.
Conclusions:
- Endothelial dysfunction, assessed by FMD% and biomarkers, is not significantly associated with the prevalence of aortic valve calcification.
- Endothelial dysfunction markers do not show an independent association with the progression of aortic valve calcification after accounting for cardiac risk factors.
Background And Aims:
Aortic valve calcification (AVC) may be associated with atherogenic processes arising from endothelial dysfunction (ED). Limited data is available about the relationship between ED, defined by flow mediated dilation (FMD%) and biomarkers, and the prevalence and progression of AVC in a multiethnic population.
Methods:
A sample of 3475 individuals from the Multi-Ethnic Study of Atherosclerosis (MESA), with both initial and repeat CT scans at a mean of 2.65 ± 0.84 years and FMD% and serologic markers of ED [ C-reactive protein (CRP), Von Willebrand factor (vWF), Plasminogen Activator Inhibitor (PAI), fibrinogen, Interleukin 6 (IL6), E-selectin and ICAM-1 (Intercellular Adhesion Molecule 1)], were analyzed. Multivariate modeling evaluated the association between ED and the prevalent AVC and AVC progression.
Results:
The median levels of FMD% was lower and vWF%, fibrinogen, IL6 and ICAM-1 were significantly higher in the AVC prevalence group versus no AVC prevalence (all p < 0.001). In the fully adjusted model for established risk factors, decreasing FMD% or increasing biomarkers was not independently associated with AVC prevalence [OR FMD% 1.028 (0.786, 1.346), CRP 0.981 (0.825, 1.168), vWF 1.132 (0.559, 2.292), PAI 1.124 (0.960, 1.316), fibrinogen 1.116 (0.424, 2.940), IL6 1.065 (0.779, 1.456), E-selectin 0.876 (0.479, 1.602) and ICAM-1 1.766 (0.834, 3.743)]. In the AVC progression group, FMD%, vWF%, fibrinogen and IL6 were significantly different (p < 0.05). After adjusting for cardiac risk factors, AVC progression was not independently associated with decreasing FMD% or increasing biomarkers [OR FMD% 1.105 (0.835, 1.463), CRP 1.014 (0.849, 1.210), vWF% 1.132 (0.559, 2.292), PAI 1.124 (0.960, 1.316), fibrinogen 0.909 (0.338, 2.443), IL6 1.061 (0.772, 1.459), E-selectin 0.794 (0.426, 1.480) and ICAM-1 0.998 (0.476, 2.092)].
Conclusions:
Endothelial dysfunction by FMD% and biomarkers is not significantly associated with the prevalence or progression of aortic valve calcification after adjustment for cardiac risk factors.
Related Concept Videos
Ethnic Identity within a Larger Culture
Relationship Formation
Atherosclerosis III: Management
Atherosclerosis I: Introduction
Ending Relationships
Heart Valves
The AV valves prevent the backflow of blood from the ventricles to the atria during ventricular contraction. These valves function with the assistance of the chordae tendineae and papillary muscles. When the ventricles are relaxed, the chordae tendineae are slack, allowing blood to flow from the atria into the...

